Antimicrobial update : DaptomycinOBERHOLZER, Christopher M; CASERTA, Mary T.The Pediatric infectious disease journal. 2005, Vol 24, Num 10, pp 919-920, issn 0891-3668, 2 p.Article

In vivo pharmacodynamic activity of daptomycinSAFDAR, Nasia; ANDES, David; CRAIG, W. A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 63-68, issn 0066-4804, 6 p.Article

EUCAST Technical Note on daptomycinClinical microbiology and infection. 2006, Vol 12, Num 6, pp 599-601, issn 1198-743X, 3 p.Article

Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved PropertiesNGUYEN, Kien T; XIAOWEI HE; BRIAN, Paul et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 4, pp 1404-1413, issn 0066-4804, 10 p.Article

DaptomycinENOCH, David A; BYGOTT, Jeanine M; DALY, Marie-Louise et al.The Journal of infection. 2007, Vol 55, Num 3, pp 205-213, issn 0163-4453, 9 p.Article

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsSTREIT, Jennifer M; JONES, Ronald N; SADER, Helio S et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 4, pp 669-674, issn 0305-7453, 6 p.Article

Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MDEISENSTEIN, Barry I; OLESON, Frederick B; BALTZ, Richard H et al.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S10-S15, SUP1Conference Paper

Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporusBALTZ, Richard H; BRIAN, Paul; MIAO, Vivian et al.Journal of industrial microbiology & biotechnology. 2006, Vol 33, Num 2, pp 66-74, issn 1367-5435, 9 p.Article

Genome Shuffling of Streptomyces roseosporus for Improving Daptomycin ProductionGUANGHAI YU; YUANSEN HU; MING HUI et al.Applied biochemistry and biotechnology. 2014, Vol 172, Num 5, pp 2661-2669, issn 0273-2289, 9 p.Article

Daptomycin: A cyclic lipopeptide Antimicrobial agentJEU, Lilyann; FUNG, Horatio B.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1728-1757, issn 0149-2918, 30 p.Article

Daptomycin: evaluation of a high-dose treatment strategyWU, Gary; ABRAHAM, Teena; RAPP, Jonathan et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 3, pp 192-196, issn 0924-8579, 5 p.Article

A Current Perspective on Daptomycin for the Clinical MicrobiologistHUMPHRIES, Romney M; POLLETT, Simon; SAKOULAS, George et al.Clinical microbiology reviews (Print). 2013, Vol 26, Num 4, pp 759-780, issn 0893-8512, 22 p.Article

Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamberHALL, Emily W; ROUSE, Mark S; JACOFSKY, David J et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 4, pp 261-265, issn 0732-8893, 5 p.Article

Lysyl-Phosphatidylglycerol Attenuates Membrane Perturbation Rather than Surface Association of the Cationic Antimicrobial Peptide 6W-RP-1 in a Model Membrane System: Implications for Daptomycin ResistanceKILELEE, Erin; POKORNY, Antje; YEAMAN, Michael R et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 10, pp 4476-4479, issn 0066-4804, 4 p.Article

Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agarJOHNSON, Alan P; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 860-862, issn 0305-7453, 3 p.Article

Estimated pKa Values for Specific Amino Acid Residues in DaptomycinJIANG QIU; LIPING YU; KIRSCH, Lee E et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 10, pp 4225-4233, issn 0022-3549, 9 p.Article

Kinetic Analysis and Modeling of Daptomycin Batch Fermentation by Streptomyces roseosporusWENYU LU; JINGHUA FAN; JIANPING WEN et al.Applied biochemistry and biotechnology. 2011, Vol 163, Num 4, pp 453-462, issn 0273-2289, 10 p.Article

Retrospective Observational Study Comparing Vancomycin Versus Daptomycin as Initial Therapy for Staphylococcus aureus InfectionsJOBSON, Synanda; MOISE, Pamela A; ESKANDARIAN, Romic et al.Clinical therapeutics. 2011, Vol 33, Num 10, pp 1391-1399, issn 0149-2918, 9 p.Article

High-dose daptomycin in documented Staphylococcus aureus infectionsBASSETTI, Matteo; NICCO, Elena; GINOCCHIO, Francesca et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 459-461, issn 0924-8579, 3 p.Article

Place de la daptomycine dans les infections ostéoarticulaires = Daptomycin in the treatment of bone and joint infectionsCARSENTI DELLAMONICA, H.Antibiotiques (Paris. Print). 2010, Vol 12, Num 3, pp 145-151, issn 1294-5501, 7 p.Article

Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer centerSMITH, Patrick F; BOOKER, Brent M; OGUNDELE, Abayomi B et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 255-259, issn 0732-8893, 5 p.Article

Single-dose Pharmacokinetics of Daptomycin in Pediatric Patients 3-24 Months of AgeBRADLEY, John S; BENZIGER, David; BOKESCH, Paula et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 9, pp 936-939, issn 0891-3668, 4 p.Article

Improvement of A21978C production in Streptomyces roseosporus by reporter-guided rpsL mutation selectionWANG, L; ZHAO, Y; LIU, Q et al.Journal of applied microbiology (Print). 2012, Vol 112, Num 6, pp 1095-1101, issn 1364-5072, 7 p.Article

Reduced pulmonary surfactant interaction of daptomycin analogs via tryptophan replacement with alternative amino acidsYONG HE; JING LI; SILVERMAN, Jared A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6248-6251, issn 0960-894X, 4 p.Article

SINGLE-DOSE PHARMACOKINETICS AND TOLERABILITY OF DAPTOMYCIN 8 TO 10 MG/ KG IN CHILDREN AGED 2 TO 6 YEARS WITH SUSPECTED OR PROVED GRAM-POSITIVE INFECTIONSABDEL-RAHMAN, Susan M; CHANDORKAR, Gurudatt; AKINS, Ronda L et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 8, pp 712-714, issn 0891-3668, 3 p.Article